CTT Pharma Adds Independent Director With NIH/NSF Experience
About CTT Pharmaceuticals Holdings, Inc. CTT has patented technology in The United States, Europe, Canada and many additional countries to allow many actives on a dissolvable strip that include but ...
Medscape18h
Personalized Neoantigen Vaccine Shows Promise in High-Risk Renal Cell Carcinoma
Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...
CTT Pharmaceutical Holdings, Inc.: CTT Pharma Adds Independent Director With NIH/NSF Experience
TAMPA, FL / ACCESS Newswire / February 5, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC PINK:CTTH) is pleased to announce adding Dr. Katherine Cole as an Independent Director for CTT. Dr. Cole. a Ph.
Someone Asked Mark Cuban About Cancer Research Being Canceled; His Surprising Answer: 'Trump Is Doing What You Do After Acquiring A Company'
When President Donald Trump's administration abruptly paused external communications, hiring, travel and grant-review panels ...
justthenews5h
Wokeness in federal agencies protects cruel, pointless animal testing, House oversight panel hears
Goodman also blamed "institutional inertia" and "circular reasoning" – that agencies had always experimented on animals – for ...
Orange County Business Journal3d
Cancer Experts Probe Declining Trust in Health Institutions
During his presidency, Nixon signed the National Cancer Act of 1971, which established the National Cancer Institute (NCI) ...
STAT3d
HPV self-collection tests must be approved for use at home
Women’s health champions like us cheered in January when the U.S. Preventive Services Task Force (USPSTF) issued a draft ...
Armed robbery in Revesby2d
OHSU Secures $1.4M for Cancer Drug Training Program
NIH grant funds immersive program to give M.D., Ph.D. postdoctoral fellows hands-on training in cancer drug development Ph.D.
The Harvard Crimson6d
Harvard’s Federal Funding Is Under Fire. Here’s What’s at Risk.
President Donald Trump’s wave of executive orders targeting funding for education sent shockwaves through Harvard this week, ...
Pharm Exec10h
Merck Launches Phase III Trial Evaluating Zilovertamab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, and prednisone against the current standard-of-care in patients with ...
Ovarian Cancer Drugs Market To Reach USD 9,857 Million By 2032, Growing At A 14.3% CAGR
Global Ovarian Cancer Drugs Market size is expected to be worth around USD 9,857 Mn by 2032 from USD 3061 Mn in 2023, growing at a CAGR of 14.3% ...
scientific-computing2d
AI helps identify cancer risk
Guo has not only been about software and assay development but also about identifying new drugs and new indications for existing drugs for the treatment of lung cancer and breast cancer. Through the ...